Asia Pacific Single-cell Analysis Market - Industry-Specific Opportunities and Trends Affecting the Growth
2022-06-03 13:44:32 UTC | Healthcare & Pharmaceuticals
MarketsandMarkets™ Research Report's View on Revenue Impact?
The Asia Pacific single-cell analysis market is projected to reach USD 1,375 million by 2025 from USD 550 million in 2020, at a CAGR of 20.1%.
Factors Responsible for Growth and In-Depth Analysis?
Increasing R&D in the pharmaceutical and biotechnology industries for complex diseases;
Pharmaceutical and biotechnology companies are major end users in the Asia Pacific single-cell analysis market. Single-cell analysis is carried out in the research and production of all biopharmaceutical products. Growth in the pharmaceutical and biotechnology sector across the Asia Pacific region serves as a direct driver for associated markets such as single-cell analysis.
Pharmaceutical and biotechnology companies utilize single-cell analysis products to achieve their clinical research goals. Biopharmaceutical companies focus on developing targeted therapies, especially for the treatment of cancer, complex diseases, and rare genetic disorders. As companies are focusing on developing targeted therapies, the need for single-cell analysis products has become imperative for determining the genetic profile of patients enrolled in clinical trials. Similarly, pharmaceutical companies are utilizing single-cell analysis instruments such as NGS technologies for biomarker research, which is a segment that has the potential to grow at a high CAGR in the coming years.
Leading Key Players and Analysis:
Some key players in the Asia Pacific single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), General Electric Company (US), Promega Corporation (US), Illumina, Inc. (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies, Inc. (US), Tecan Group Ltd. (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), 10x Genomics (US), Fluxion Biosciences (US), Menarini Silicon Biosystems, Inc. (Italy), bioMérieux SA (France), Oxford Nanopore Technologies (UK), Cytek Biosciences (US), Corning Incorporated (US), Apogee Flow Systems Ltd. (UK), NanoCellect Biomedical (US), and On-chip Biotechnologies Co., Ltd. (Japan).
Geographical Analysis in Detailed?
The Asia Pacific single-cell analysis market is segmented into Japan, China, India, South Korea, Singapore, Australia, Southeast Asia, and the Rest of Asia Pacific. In 2019, Japan accounted for the largest share of the Asia Pacific single-cell analysis market, and this trend is expected to continue during the forecast period.
In terms of market share, China closely followed Japan in 2019. However, in the next five years, the share of Japan is expected to increase in the APAC single-cell analysis market as it is estimated to witness higher CAGR than China. This can be attributed to the large geriatric population, increasing life science research activities, and growing focus on personalized medicine in Japan.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=257201069
In 2019, consumables segment accounted for the largest share of the Asia Pacific single-cell analysis market”
Based on product, the Asia Pacific single-cell analysis market is segmented into consumables and instruments. The consumables segment includes beads, microplates, reagents, assay kits, and other consumables. The instruments segment includes flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems, microarrays, and other instruments. The consumables segment accounted for the largest market share in 2019. This segment is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the frequent purchase of these products as compared to instruments, which are considered as a one-time investment, and their wide applications in research and exosome analysis.
In 2019, human cells segment accounted for the largest share in the market”
The Asia Pacific single-cell analysis market is segmented into human cells, animal cells, and microbial cells based on cell type. The human cells segment accounted for the largest market share in 2019, owing to the high adoption of human cells to develop novel cancer therapies.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=257201069